5-Phenyl-7-(Trifluoromethyl)-1,3-Dihydro-1,4-Benzodiazepin-2-One

CAS: 2285-16-7

Ref. 3D-FP97428

Produktinformation

• Name: 5-Phenyl-7-(Trifluoromethyl)-1,3-Dihydro-1,4-Benzodiazepin-2-One
• Marke: Biosynth
• Beschreibung: 5-Phenyl-7-(Trifluoromethyl)-1,3-Dihydro-1,4-Benzodiazepin-2-One is a pyrethroid that has been shown to have an effective dose of 10 μg/kg in pharmacological tests. It has been shown to modulate hydrogen bond formation and the hydrophobic effects of diazepam. 5-Phenyl-7-(Trifluoromethyl)-1,3-Dihydro-1,4-Benzodiazepin-2-One is a monomer that can be used for the treatment of cancer. This active compound has been found to bind to the benzodiazepine binding site on GABA receptors in the brain and has been shown to induce digitonin release from nerve endings. It also binds with carbonyl groups which are found on proteins and nucleic acids.

Chemische Eigenschaften

• Molekulargewicht: 304.27 g/mol
• Formel: C₁₆H₁₁F₃N₂O
• Reinheit: Min. 95%
• InChl: InChI=1S/C16H11F3N2O/c17-16(18,19)11-6-7-13-12(8-11)15(20-9-14(22)21-13)10-4-2-1-3-5-10/h1-8H,9H2,(H,21,22)
• InChI Key: InChIKey=UUBMOUNXQFMBQF-UHFFFAOYSA-N
• SMILES: O=C1CN=C(c2ccccc2)c2cc(C(F)(F)F)ccc2N1